Table 3.
Influence of location of BCCs in the number of MMS stages required, comparing different high-risk subunits (periocular area, nose, perioral area, and ear).
| Location | Mean of MMS stages (± SD) | p-value |
|---|---|---|
| Periocular | 2.29 (± 0.95) | |
| Periocular * ear | 2.29 * 1.25 | 0.048a |
| Periocular * nose | 2.29 * 1.42 | 0.027a |
| Periocular * perioral | 2.29 * 1.36 | 0.054a |
| Nose | 1.42 (± 0.59) | |
| Nose * ear | 1.42 * 1.25 | 1.000 |
| Nose * perioral | 1.42 * 1.36 | 1.000 |
| Perioral | 1.36 (± 0.67) | |
| Perioral * ear | 1.36 * 1.25 | 1.000 |
| Ear | 1.25 (± 0.46) |
The significance level is 0.05 (value in bolda). Significance values have been adjusted by the Bonferroni correction for multiple tests.